LncmiRHG-MIR100HG: A new budding star in cancer
MIR100HG, also known as lncRNA mir-100-let-7a-2-mir-125b-1 cluster host gene, is a new and critical regulator in cancers in recent years. MIR100HG is dysregulated in various cancers and plays an oncogenic or tumor-suppressive role, which participates in many tumor cell biology processes and cancer-r...
Main Authors: | Yingnan Wu, Zhenzhen Wang, Shan Yu, Dongzhe Liu, Litao Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.997532/full |
Similar Items
-
Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing chemotherapy-induced-neutropenia in early-stage breast cancer patients
by: Yantao Jiang, et al.
Published: (2023-07-01) -
The rhg1‐a (Rhg1 low‐copy) nematode resistance source harbors a copia‐family retrotransposon within the Rhg1‐encoded α‐SNAP gene
by: Adam M. Bayless, et al.
Published: (2019-08-01) -
Comparison of Two Regimens of RhG-CSF in Neutropenic Neonatal Septicemia: A Randomized Clinical Trial
by: Fatemeh Nayeri, et al.
Published: (2011-09-01) -
Comparison of Two Regimens of RhG-CSF in Neutropenic Neonatal Septicemia: A Randomized Clinical Trial
by: Fatemeh Nayeri, et al.
Published: (2011-09-01) -
Efficacy and safety of PEG-rhG-CSF in preventing chemoradiotherapy-induced neutropenia in patients with locally advanced cervical cancer
by: Weiwei Li, et al.
Published: (2023-03-01)